We are live on ! Find out more
SPPI

Spectrum Pharmaceuticals Inc
SPPI

Delisted

SPPI was delisted on the 31st of July, 2023.

Back to rankings

128 hedge funds and large institutions have $353M invested in Spectrum Pharmaceuticals Inc in 2017 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 55 increasing their positions, 35 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

127% more call options, than puts

Call options by funds: $583K | Put options by funds: $257K

57% more repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 35

53% more capital invested

Capital invested by funds: $231M → $353M (+$123M)

8% less funds holding

Funds holding: 139 → 128 (-11)

25% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 16

Holders
128
Holders Change
-11
Holders Change %
-7.91%
% of All Funds
3.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
55
Reduced
35
Closed
16
Calls
$583K
Puts
$257K
Net Calls
+$326K
Net Calls Change
+$244K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$65.1M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$4.89M
3
State Street
State Street
Massachusetts
+$4.1M
4
Renaissance Technologies
Renaissance Technologies
New York
+$2.81M
5
NI
Numeric Investors
Massachusetts
+$2.15M

Top Sellers

Rank Fund Capital Flow
1
Deutsche Bank
Deutsche Bank
Germany
-$3.84M
2
Charles Schwab
Charles Schwab
California
-$3.11M
3
Millennium Management
Millennium Management
New York
-$2.01M
4
Citadel Advisors
Citadel Advisors
Florida
-$1.32M
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$861K
Name Holding Trade Value Shares
Change 		Change in
Stake
Walleye Trading
126
Walleye Trading
New York
$304 +$261K +46,700 New
Susquehanna International Group
127
Susquehanna International Group
Pennsylvania
– -$658K -117,721 Closed
SCA
128
Secor Capital Advisors
New York
– -$514K -115,953 Closed
IR
129
IAT Reinsurance
New York
– -$336K -75,796 Closed
Two Sigma Investments
130
Two Sigma Investments
New York
– -$321K -72,350 Closed
ACM
131
Alethea Capital Management
Washington
– -$109K -24,577 Closed
SCM
132
Stevens Capital Management
Pennsylvania
– -$96K -21,744 Closed
DTL
133
Dynamic Technology Lab
Singapore
– -$96K -21,706 Closed
PP
134
Paloma Partners
Connecticut
– -$89K -20,009 Closed
PAM
135
Paradigm Asset Management
New York
– -$70K -15,800 Closed
Squarepoint
136
Squarepoint
New York
– -$59K -13,375 Closed
HSBC Holdings
137
HSBC Holdings
United Kingdom
– -$59K -13,351 Closed
VKH
138
Virtu KCG Holdings
New York
– -$51K -11,568 Closed
TRCT
139
Tower Research Capital (TRC)
New York
– -$29K -6,425 Closed
ADL
140
Asset Dedication LLC
California
– -$22K -5,000 Closed
Loomis, Sayles & Company
141
Loomis, Sayles & Company
Massachusetts
– -$4K -926 Closed
AG
142
Advisor Group
Arizona
– -$1K -235 Closed
2 3 4 5
6

SPPI Hedge Fund Activity: Q1 2017 in Review

128 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q1 2017, worth a combined $353M — up 53% from $231M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of SPPI and 12 opened new positions — a net loss of 4 holders — while 35 trimmed existing stakes and 55 added.

The largest buyer was BlackRock, adding an estimated $65.1M. The largest seller was Deutsche Bank, cutting an estimated $3.84M.

  • 128 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q1 2017, down from 139 in Q4 2016.
  • Funds reported $353M of Spectrum Pharmaceuticals Inc stock for Q1 2017, up 53% quarter-over-quarter.
  • 12 funds opened new Spectrum Pharmaceuticals Inc positions in Q1 2017 and 16 closed out, a net change of -4 holders.
  • The largest Spectrum Pharmaceuticals Inc buyer in Q1 2017 was BlackRock, an estimated $65.1M added.
  • The largest Spectrum Pharmaceuticals Inc seller in Q1 2017 was Deutsche Bank, an estimated $3.84M sold.

Based on aggregated 13F filings for Q1 2017.